Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Beate Maruhn-Debowski"'
Autor:
G. Giers, Rüdiger E. Scharf, Rainer B. Zotz, Markus Nauck, Winfried März, Beate Maruhn-Debowski, Bernhard R. Winkelmann
Publikováno v:
Thrombosis and Haemostasis. 79:731-735
SummaryConflicting results of an association between the human platelet antigen 1b (HPA-1b or PlA2) allele and the risk of myocardial infarction and coronary artery disease have been reported. To assess the reason for this discrepancy, we determined
Autor:
Bernd Grabensee, Christine Kurschat, Ruediger E. Scharf, Ljerka Ostojic, Rainer B. Zotz, Gerd R. Hetzel, Robert Loncar, Christoph Sucker, Beate Maruhn-Debowski
Publikováno v:
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. 15(3)
Factor V Leiden (FVL) mutation and prothrombin G20210A mutation are common hereditary risk factors for venous thrombosis. In the current study, 40 patients (mean age ± standard deviation, 35 ± 11 years) and 764 healthy control subjects (mean age ±
Autor:
Gerd R. Hetzel, Robert Loncar, Firuseh Farokhzad, Rüdiger E. Scharf, Rainer B. Zotz, Beate Maruhn-Debowski, Bernd Grabensee, Christine Kurschat, Christoph Sucker
Publikováno v:
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. 15(3)
In this study, we assessed the potential role of the TT genotype of the gene of the methylenetetrahydrofolate reductase for the manifestation of thrombotic microangiopathies, enrolling 40 affected patients (mean age [± standard deviation] 35 ± 11 y
Autor:
Ljerka Ostojic, Christoph Sucker, Bernd Grabensee, Beate Maruhn-Debowski, Gerd R. Hetzel, Rainer B. Zotz, Michael Schmitz, Rüdiger E. Scharf
Publikováno v:
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. 15(4)
Thrombotic microangiopathies are life-threatening disorders characterized by vascular microthromboses, schistocytic hemolytic anemia, and thrombocytopenia. Although recent research has partially explained the pathogenesis of these rare entities, the
Autor:
Bernd Grabensee, Christine Kurschat, Firuseh Farokhzad, Rainer B. Zotz, Christoph Sucker, Rüdiger E. Scharf, Beate Maruhn-Debowski, Gerd R. Hetzel
Publikováno v:
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. 15(2)
The 34 Leu (100T) variant of the factor XIII Val34Leu (G100T-) polymorphism slows down fibrinolysis and has been proposed as a thrombotic risk factor. In this pilot study, we enrolled 40 patients (mean age ± SD = 38 ± 11 years) and 728 controls to
Autor:
Gerd Ruediger Hetzel, Beate Maruhn-Debowski, Rainer B. Zotz, Christoph Sucker, Bernd Grabensee, Fieras Dahhan, Christine Kurschat, Firuseh Farokhzad, Ruediger E. Scharf, Michael Schmitz
Publikováno v:
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 22(5)
Background. Thrombotic microangiopathies are characterized by microvascular thrombosis, consequently leading to microangiopathic haemolytic anaemia, thrombocytopenia and organ dysfunction. Although recent research has elucidated the pathogenesis of t
Publikováno v:
British journal of haematology. 96(1)
Genotyping of platelet alloantigens with the possibility of using any type of cellular material as a source of DNA has become a preferred procedure, particularly in thrombocytopenic patients when platelet counts are too low for phenotyping. Recently